emergence agitation
Conditions
Interventions
Experimental group:active-tDCS group
Control group:sham-tDCS group
Sponsors
Huashan Hospital Affiliated to Fudan University
Eligibility
Sex/Gender
Male
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. From October 2023 to May 2024, patients aged > 18 years who underwent prostatectomy under general anesthesia; 2. Patients with ASA classification I-III; 3. The informed consent has been signed.
Exclusion criteria
Exclusion criteria: 1. Preoperative history of neurological and psychiatric disorders (such as schizophrenia, epilepsy, Parkinson's disease, or myasthenia gravis); 2. The patient with a history of alcohol abuse; 3. The patient with a history of craniocerebral trauma and surgery or a history of craniocerebral tumors; 4. The patient with visual and hearing impairments and communication difficulties; 5. The patient with simplified mental state scale (MMSE score) less than 15; 6. The patient with severe cardiovascular, liver or renal problems or with the preoperative American Association of Anesthesiologists (ASA classfication) greater than level III; 7. The patient who has internal metallic implants or has electronic implants; 8. Participated in or is currently participating in other clinical studies 3 months before enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| incidence of emergence agitation;severity of emergence agitation; | — |
Secondary
| Measure | Time frame |
|---|---|
| wake-up time;incidence of postoperative delirium;Postoperative quality of recovery score, QoR-15;Postoperative adverse reactions;EEG analysis; | — |
Countries
China
Contacts
Public ContactYingwei Wang
Huashan Hospital Affiliated to Fudan University
Outcome results
None listed